Results 311 to 320 of about 5,057,415 (322)
Some of the next articles are maybe not open access.
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Nature, 2020Zhenming Jin+30 more
semanticscholar +1 more source
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Science, 2002For at least 30 years, matrix metalloproteinases (MMPs) have been heralded as promising targets for cancer therapy on the basis of their massive up-regulation in malignant tissues and their unique ability to degrade all components of the extracellular ...
L. Coussens, B. Fingleton, L. Matrisian
semanticscholar +1 more source
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Nature Reviews Clinical Oncology, 2021D. Doroshow+9 more
semanticscholar +1 more source
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
Nature Reviews Clinical Oncology, 2021M. Dias+3 more
semanticscholar +1 more source
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Nature Reviews Microbiology, 2005K. Brogden
semanticscholar +1 more source
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Nature, 2005H. Bryant+9 more
semanticscholar +1 more source
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Nature Reviews Clinical Oncology, 2020L. Galluzzi+4 more
semanticscholar +1 more source
SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
Nature Reviews Cardiology, 2020M. Cowie, M. Fisher
semanticscholar +1 more source
Anticancer activities of histone deacetylase inhibitors
Nature reviews. Drug discovery, 2006Jessica E. Bolden+2 more
semanticscholar +1 more source
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Nature Biotechnology, 2019A. Zhavoronkov+21 more
semanticscholar +1 more source